United States Pemphigus Vulgaris Treatment Market Set for Rapid Growth Amid Rising Autoimmune Disease Cases 2025 | Top key players - Novartis AG, Sanofi, AbbVie Inc.

Market Size and Growth:

The Global Pemphigus Vulgaris Treatment Market size reached US$ 473.4 million in 2023 and is expected to reach US$ 896.1 million by 2031 growing with a CAGR of 8.3% during the forecast period 2024-2031.

The Pemphigus Vulgaris Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/pemphigus-vulgaris-treatment-market?sz

The Pemphigus Vulgaris Treatment Market encompasses therapies, drugs, and interventions designed to manage and treat pemphigus vulgaris, a rare autoimmune blistering disorder. It includes corticosteroids, immunosuppressants, biologics, and emerging therapies aimed at reducing symptoms, preventing disease progression, and improving patient quality of life. Market growth is driven by rising disease awareness and advancements in targeted treatments.

Recent Key Developments of United States (U.S):

July 2025: Novel Targeted Therapy Research: Publication of new research highlighting the potential of PC111 (a non-immunosuppressive, targeted therapy) to revolutionize treatment for PV by preventing blister formation rapidly.

Ongoing Clinical Trial Recruitment (May-July 2025): The RESET-PVTM Phase 1/2 trial for the investigational CD19-CAR T cell therapy CABA-201 in PV patients continued to recruit.

Ongoing Clinical Trial Recruitment (May-July 2025): The Phase 1 safety and dosing study of DSG3-CAART (a different autologous CAR T cell therapy) in patients with active, mucosal-dominant PV was actively recruiting.

Ongoing Clinical Trial Recruitment (May-July 2025): The open-label extension trial assessing the long-term safety and efficacy of the subcutaneous formulation of the FcRn inhibitor efgartigimod PH20 SC in adult pemphigus (PV/PF) participants was ongoing.

June 2025: Broader Biologic Approvals Impact: While for a related but distinct disease, the FDA approval of Dupilumab (Dupixent) as the first targeted therapy for Bullous Pemphigoid (another autoimmune blistering disease) signals a supportive regulatory and market trend for targeted biologics in the broader Pemphigus group.

List of the Key Players in the Pemphigus Vulgaris Treatment Market:

F. Hoffmann-La Roche Ltd.
Pfizer Inc
Teva Pharmaceutical Industries
Novartis AG
Sanofi
AbbVie Inc
AstraZeneca
Zydus Group
GSK Plc
Syntimmune.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=pemphigus-vulgaris-treatment-market

Segments Covered in the Pemphigus Vulgaris Treatment Market:

By Treatment Type: Corticosteroid, Immunosuppressants, Biological Therapies, Intravenous Immunoglobulin (IVIG) Therapy, Others.

By Route of Administration: Parenteral, Subcutaneous, Oral.

By End User: Hospitals & Clinics, Specialty Dermatology Clinics, Research & Academic Laboratories.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pemphigus-vulgaris-treatment-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Pemphigus Vulgaris Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Pemphigus Vulgaris Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Pemphigus Vulgaris Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Pemphigus Vulgaris Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Pemphigus Vulgaris Treatment Market in 2025?
◆ What is the projected growth rate of the Pemphigus Vulgaris Treatment Market through 2033?
◆ Who are the key players in the Pemphigus Vulgaris Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.